You are here: Industry Insights > Market News > Bristol-Myers Squibb to Take Part in Cowen and Company 38th Annual Global Health Care Conference

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Avatrombopag Maleate

BioHub® Magnetic Separator

Avatrombopag

Ursodeoxycholic acid

Troxerutin

CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

Bristol-Myers Squibb to Take Part in Cowen and Company 38th Annual Global Health Care Conference

biospaceMarch 06, 2018

Tag: Bristol-Myers Squibb , healthcare

Favorites

Bristol-Myers Squibb Company (NYSE:BMY) will participate in the Cowen and Company 38th Annual Global Health Care Conference on Monday, March 12, 2018, in Boston. Giovanni Caforio, chairman and chief executive officer and Fouad Namouni, head of oncology development will answer questions about the company at 2:50 p.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Register as Visitor to CPhI China 2018!

Previous:AcelRx Pharmaceuticals to Participate at Three Upcoming Investor Events in March

Next:ArQule Reports Fourth Quarter and Full Year 2017 Financial Results

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

Bristol-Myers Squibb to Take Part in Cowen and Company 38th Annual Global Health Care Conference | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

Juniper Berries Powder for Healthcare Supplement

Nutritional Healthcare Supplement OEM private label Enzyme Juice Prices Fresh Noni Fruit Powder

1%-10% Withanolide Ashwagandha Extract for Healthcare Products

Pet Plastic Amber Solid Pill Bottle Healthcare Supplement Container Withscrew Cap 250ml

Pet Plastic Amber Solid Pill Bottle Healthcare Supplement Container Withscrew Cap 70ml

Wellgreen Plant Factory Healthcare Supplement CAS 5985-28-4 Citrus Aurantium Synephrine Extract

Pet Plastic Amber Solid Pill Bottle Healthcare Supplement Container Withscrew Cap 75ml

Pet Plastic Amber Solid Pill Bottle Healthcare Supplement Container Withscrew Cap 50ml

Pet Plastic Amber Solid Pill Bottle Healthcare Supplement Container Withscrew Cap 300ml

Hot Selling Healthcare Supplement L-Proline

Bristol-Myers Squibb to Take Part in Cowen and Company 38th Annual Global Health Care Conference

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

You may likeMore>>

You may like
More>>